Chronic daily headache

por Spierings, Egilius L. H.
Publicado 2003

Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review

por Silberstein, Stephen, Spierings, Egilius L. H., Kunkel, Todd
Publicado 2023

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomize...

por Gimbel, Joseph, Spierings, Egilius L.H., Katz, Nathaniel, Xiang, Qinfang, Tzanis, Evan, Finn, Andrew
Publicado 2016

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

por Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Ettrup, Anders, Shen, Vivienne
Publicado 2021

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of epis...

por Munjal, Sagar, Brand-Schieber, Elimor, Allenby, Kent, Spierings, Egilius L.H., Cady, Roger K., Rapoport, Alan M.
Publicado 2017

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate respons...

por Spierings, Egilius L. H., Ning, Xiaoping, Ramirez Campos, Verena, Cohen, Joshua M., Barash, Steve, Buse, Dawn C.
Publicado 2021

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlle...

por Spierings, Egilius L. H., Kärppä, Mikko, Ning, Xiaoping, Cohen, Joshua M., Campos, Verena Ramirez, Yang, Ronghua, Reuter, Uwe
Publicado 2021

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

por Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Publicado 2021

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

por Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Publicado 2021